China Pharma Holdings (CPHI) Cash from Investing Activities (QoQ) (2010 - 2025)
China Pharma Holdings (CPHI) Cash from Investing Activities (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - |
| 2 | Teva Pharmaceutical Industries | 36.02 Bn | 32.28 Bn | 1.97 Bn |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.94 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.35 Bn | 18.54 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | China Pharma Holdings | 32.25 Mn | 32.08 Mn | 285,487.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 85.79% |
| Sep 30, 2025 | -24.68% |
| Jun 30, 2025 | 44.17% |
| Mar 31, 2025 | 78.62% |
| Dec 31, 2024 | -3,059.35% |
| Dec 31, 2023 | 93.29% |
| Sep 30, 2023 | -1,598.67% |
| Jun 30, 2023 | -91.96% |
| Mar 31, 2023 | 105.24% |
| Dec 31, 2022 | 110.80% |
| Sep 30, 2022 | -44.07% |
| Jun 30, 2022 | -12,501.80% |
| Mar 31, 2022 | 80.29% |
| Dec 31, 2021 | 98.30% |
| Dec 31, 2020 | 189.65% |
| Sep 30, 2020 | 47.34% |
| Jun 30, 2020 | -41.65% |
| Mar 31, 2020 | -591.94% |
| Dec 31, 2019 | -311.97% |
| Sep 30, 2019 | -3,819.82% |